Moscow, J. A., Fojo, T. & Schilsky, R. L. The evidence framework for precision cancer medicine. Nat. Rev. Clin. Oncol. 15, 183–192 (2018).
Eisenhauer, E. A. et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur. J. Cancer 45, 228–247 (2009).
Litière, S., Collette, S., de Vries, E. G., Seymour, L. & Bogaerts, J. RECIST—learning from the past to build the future. Nat. Rev. Clin. Oncol. 14, 187–192 (2017).
Basu, A. et al. An interactive resource to identify cancer genetic and lineage dependencies targeted by small molecules. Cell 154, 1151–1161 (2013).
Jonas, O. et al. An implantable microdevice to perform high-throughput in vivo drug sensitivity testing in tumors. Sci. Transl. Med. 7, 284ra57 (2015).
Martinez Molina, D. et al. Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay. Science 341, 84–87 (2013).
Jones, L. H. & Neubert, H. Clinical chemoproteomics—opportunities and obstacles. Sci. Transl. Med. 9, eaaf7951 (2017).
Gerry, C. J. & Schreiber, S. L. Chemical probes and drug leads from advances in synthetic planning and methodology. Nat. Rev. Drug Discov. 17, 333–352 (2018).
Shao, H. et al. New technologies for analysis of extracellular vesicles. Chem. Rev. 118, 1917–1950 (2018).
Colombo, M., Raposo, G. & Théry, C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu. Rev. Cell Dev. Biol. 30, 255–289 (2014).
van Niel, G., D’Angelo, G. & Raposo, G. Shedding light on the cell biology of extracellular vesicles. Nat. Rev. Mol. Cell Biol. 19, 213–228 (2018).
Minciacchi, V. R., Freeman, M. R. & Di Vizio, D. Extracellular vesicles in cancer: exosomes, microvesicles and the emerging role of large oncosomes. Semin. Cell Dev. Biol. 40, 41–51 (2015).
Mathieu, M., Martin-Jaular, L., Lavieu, G. & Théry, C. Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication. Nat. Cell Biol. 21, 9–17 (2019).
Shao, H. et al. Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy. Nat. Med. 18, 1835–1840 (2012).
Choi, D. S., Kim, D. K., Kim, Y. K. & Gho, Y. S. Proteomics of extracellular vesicles: exosomes and ectosomes. Mass Spectrom. Rev. 34, 474–490 (2015).
Valadi, H. et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654–659 (2007).
Skog, J. et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell Biol. 10, 1470–1476 (2008).
Maas, S. L. N., Breakefield, X. O. & Weaver, A. M. Extracellular vesicles: unique intercellular delivery vehicles. Trends Cell Biol. 27, 172–188 (2017).
Wang, Z. et al. Dual-selective magnetic analysis of extracellular vesicle glycans. Matter 2, 150–166 (2020).
Tan, X., Lambert, P. F., Rapraeger, A. C. & Anderson, R. A. Stress-induced EGFR trafficking: mechanisms, functions, and therapeutic implications. Trends Cell Biol. 26, 352–366 (2016).
Xin, H., Namgung, B. & Lee, L. P. Nanoplasmonic optical antennas for life sciences and medicine. Nat. Rev. Mater. 3, 228–243 (2018).
Ligler, F. S. & Gooding, J. J. Lighting up biosensors: now and the decade to come. Anal. Chem. 91, 8732–8738 (2019).
Li, D. et al. BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models. Oncogene 27, 4702–4711 (2008).
Jewett, J. C. & Bertozzi, C. R. Cu-free click cycloaddition reactions in chemical biology. Chem. Soc. Rev. 39, 1272–1279 (2010).
Patterson, D. M., Nazarova, L. A. & Prescher, J. A. Finding the right (bioorthogonal) chemistry. ACS Chem. Biol. 9, 592–605 (2014).
Lanning, B. R. et al. A road map to evaluate the proteome-wide selectivity of covalent kinase inhibitors. Nat. Chem. Biol. 10, 760–767 (2014).
Rutkowska, A. et al. A modular probe strategy for drug localization, target identification and target occupancy measurement on single cell level. ACS Chem. Biol. 11, 2541–2550 (2016).
Shao, H. et al. Chip-based analysis of exosomal mRNA mediating drug resistance in glioblastoma. Nat. Commun. 6, 6999 (2015).
Im, H. et al. Label-free detection and molecular profiling of exosomes with a nano-plasmonic sensor. Nat. Biotechnol. 32, 490–495 (2014).
Lim, C. Z. J. et al. Subtyping of circulating exosome-bound amyloid β reflects brain plaque deposition. Nat. Commun. 10, 1144 (2019).
Cross, D. A. et al. AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer. Cancer Disco. 4, 1046–1061 (2014).
Sandfeld-Paulsen, B. et al. Exosomal proteins as prognostic biomarkers in non-small cell lung cancer. Mol. Oncol. 10, 1595–1602 (2016).
Hirsch, F. R. et al. Lung cancer: current therapies and new targeted treatments. Lancet 389, 299–311 (2017).
Hoelder, S., Clarke, P. A. & Workman, P. Discovery of small molecule cancer drugs: successes, challenges and opportunities. Mol. Oncol. 6, 155–176 (2012).
Wagner, J. A. Strategic approach to fit-for-purpose biomarkers in drug development. Annu. Rev. Pharmacol. Toxicol. 48, 631–651 (2008).
Tuntland, T. et al. Implementation of pharmacokinetic and pharmacodynamic strategies in early research phases of drug discovery and development at Novartis Institute of Biomedical Research. Front Pharm. 5, 174 (2014).
Arrowsmith, C. H. et al. The promise and peril of chemical probes. Nat. Chem. Biol. 11, 536–541 (2015).
Meehan, B., Rak, J. & Di Vizio, D. Oncosomes—large and small: what are they, where they came from? J. Extracell. Vesicles 5, 33109 (2016).
Schreiber, C. L. & Smith, B. D. Molecular conjugation using non-covalent click chemistry. Nat. Rev. Chem. 3, 393–400 (2019).
Ho, N. R. Y. et al. Visual and modular detection of pathogen nucleic acids with enzyme–DNA molecular complexes. Nat. Commun. 9, 3238 (2018).
Sundah, N. R. et al. Barcoded DNA nanostructures for the multiplexed profiling of subcellular protein distribution. Nat. Biomed. Eng. 3, 684–694 (2019).
Gooding, J. J. & Gaus, K. Single-molecule sensors: challenges and opportunities for quantitative analysis. Angew. Chem. Int. Ed. 55, 11354–11366 (2016).
Wu, X. et al. Exosome-templated nanoplasmonics for multiparametric molecular profiling. Sci. Adv. 6, eaba2556 (2020).
Lim, C. Z. J., Natalia, A., Sundah, N. R. & Shao, H. Biomarker organization in circulating extracellular vesicles: new applications in detecting neurodegenerative diseases. Adv. Biosyst. 4, e1900309 (2020).
Lim, C. Z. J., Zhang, L., Zhang, Y., Sundah, N. R. & Shao, H. New sensors for extracellular vesicles: insights on constituent and associated biomarkers. ACS Sens. 5, 4–12 (2020).
Borrebaeck, C. A. Precision diagnostics: moving towards protein biomarker signatures of clinical utility in cancer. Nat. Rev. Cancer 17, 199–204 (2017).
Yeh, E. C. et al. Self-powered integrated microfluidic point-of-care low-cost enabling (SIMPLE) chip. Sci. Adv. 3, e1501645 (2017).
Yelleswarapu, V. et al. Mobile platform for rapid sub-picogram-per-milliliter, multiplexed, digital droplet detection of proteins. Proc. Natl Acad. Sci. USA 116, 4489–4495 (2019).
Théry, C. et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J. Extracell. Vesicles 7, 1535750 (2018).
Bianco, G., Forli, S., Goodsell, D. S. & Olson, A. J. Covalent docking using AutoDock: two-point attractor and flexible side chain methods. Protein Sci. 25, 295–301 (2016).
Checkout PrimeXBT
Trade with the Official CFD Partners of AC Milan
Source: https://www.nature.com/articles/s41565-021-00872-w
